Motpoly Xr Capsule, Extended Release
Product Images NDC 73289-0065

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Motpoly Xr (NDC 73289-0065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aucta Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-100mg (Container 100mg)

Motpoly XR is a medication in the form of extended-release capsules containing 100 mg of lacosamide. The recommended dosage should be obtained from the prescribing information. The medication guide should be issued to each patient. The capsules must not be opened, chewed, or crushed, but swallowed whole with liquid. The drug must be stored away from the reach of children. The capsule bottle contains 60 capsules. The manufacturer is Aucta Pharmaceuticals, Inc in Piscataway, NJ.*

FDA Label Image

Container-150mg (Container 150mg)

This is a medication description. The medication is called Motpoly XR (lacosamide) and it comes in extended-release 150mg capsules. The package includes 60 capsules and a medication guide. The recommended dosage information can be found in the prescribing information. The capsules should be swallowed whole with liquid and should not be opened, chewed, or crushed. This medication is manufactured by Aucta Pharmaceuticals Inc. in Piscataway, New Jersey.*

FDA Label Image

Container-200mg (Container 200mg)

This is a description of a drug called Lacosamide. The drug comes in the form of capsules, with each containing 200 g of Lacosamide. The recommended dosage is not provided. However, it is indicated that the user should see the prescribing information. The manufacturer of the drug is Aucta Pharmaceuticals, Inc., and the drug is an extended-release capsule that should not be opened, chewed, or crushed. The drug should be kept out of reach of children. Additionally, the accompanying Medication Guide (1B5038-00) is required for each patient. The NDC code for this drug is 73289-0065-2, and it comes in a pack of 60 capsules.*

FDA Label Image

Chemical-structure (Lacosamide 01)

FDA Label Image

Fig-1 (Lacosamide 02)

The text is a description of Figure 1 showing the median percentage reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose in Study 4 and Study 2. The text also mentions the statistically significant difference compared to placebo.*

FDA Label Image

Fig-2 (Lacosamide 03)

FDA Label Image

Professional-sample-carton (Professional Sample Carton)

Motpoly XR is a medication in extended-release capsule form, containing 100mg of lacosamide per capsule. It is a prescription medication requiring an accompanying medication guide and is for sale only to authorized healthcare professionals. No additional information is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.